Search - tctmd.com

Displaying 621 - 640 of 951

Sort: Relevancy | Date

Presentation TCT 2017

Valvular Heart Disease: Diagnosis and Treatment Options 2017

Presenter: Grzegorz L. Kaluza, Jose M. Wiley, Nicola Corvaja

October 29, 2017

Presentation

Mid- and Long-term Outcome Comparisons of Absorb BVS vs Everolimus-Eluting Stent

October 17, 2017

Presentation

Death and Dialysis After TAVR:Analysis of STS/ACC TVT Registry

October 17, 2017

Presentation

Association Between Use of Antithrombotic Medication and Hematuria-Related Complications

October 09, 2017

Presentation

High-Sensitivity Cardiac Troponin and Risk Stratification of Pts With Renal Impairment Presenting With Suspected ACS

October 06, 2017

Presentation CDM 2017

Can Heart Disease be Eventually Abolished? The PCSK9 Revolution

Presenter: Robert A. Vogel

October 06, 2017

Presentation

Coronary CT Angiography vs Functional Stress Testing for Patients With Suspected CAD

October 05, 2017

Presentation CDM 2017

Cardiopulmonary Arrest: Therapeutic Hypothermia and Compression Only CPR

Presenter: Jason Bartos

October 05, 2017

Presentation CDM 2017

Can CHD and DM be Prevented? The Answer is on Your Plate

Presenter: Robert A. Vogel

October 05, 2017

Presentation CDM 2017

Primary Aldosteronism & Implications for Primary Hypertension

Presenter: Richard J. Auchus

October 05, 2017

Presentation

Impact of Gender on Arterial Revascularization Strategies for CABG

September 29, 2017

Presentation

Association of PVR With 1-Year Outcomes After TAVR With Sapien 3 Valve

September 27, 2017

Presentation VIVA 2017

What is the Right Antiplatelet Therapy for Symptomatic Carotid Disease?

Presenter: William Gray

September 21, 2017

Presentation VIVA 2017

Is Aspirin Really a Class I Medication in Peripheral Artery Disease?

Presenter: Ehrin J. Armstrong

September 19, 2017

Presentation

Impact of Frailty on Outcomes in Patients Undergoing Percutaneous Mitral Valve Repair

September 16, 2017

Presentation

Global Geographic Variation in Patient Characteristics in PCI Clinical Trials

September 15, 2017

Presentation iASSESS 2017

Radial Access and Related Complications

Presenter: Jordan Safirstein

August 30, 2017

Presentation ESC 2017

Undertreatment of Female Patients in Lipid-Lowering for Secondary Prevention in Europe, Canada, South Africa, Middle East and China

Presenter: Anselm K. Gitt

August 30, 2017

Presentation

Differential Blood Pressure Effects of Ibuprofen, Naproxen, and Celecoxib in Patients with Arthritis

August 30, 2017

Presentation ESC 2017

The Viborg Vascular (VIVA) Randomised Screening Trial

Presenter: Jes Lindholt

August 29, 2017

Advertisement

Valvular Heart Disease: Diagnosis and Treatment Options 2017

Mid- and Long-term Outcome Comparisons of Absorb BVS vs Everolimus-Eluting Stent

Death and Dialysis After TAVR:Analysis of STS/ACC TVT Registry

Association Between Use of Antithrombotic Medication and Hematuria-Related Complications

High-Sensitivity Cardiac Troponin and Risk Stratification of Pts With Renal Impairment Presenting With Suspected ACS

Can Heart Disease be Eventually Abolished? The PCSK9 Revolution

Coronary CT Angiography vs Functional Stress Testing for Patients With Suspected CAD

Cardiopulmonary Arrest: Therapeutic Hypothermia and Compression Only CPR

Can CHD and DM be Prevented? The Answer is on Your Plate

Primary Aldosteronism & Implications for Primary Hypertension

Impact of Gender on Arterial Revascularization Strategies for CABG

Association of PVR With 1-Year Outcomes After TAVR With Sapien 3 Valve

What is the Right Antiplatelet Therapy for Symptomatic Carotid Disease?

Is Aspirin Really a Class I Medication in Peripheral Artery Disease?

Impact of Frailty on Outcomes in Patients Undergoing Percutaneous Mitral Valve Repair

Global Geographic Variation in Patient Characteristics in PCI Clinical Trials

Radial Access and Related Complications

Undertreatment of Female Patients in Lipid-Lowering for Secondary Prevention in Europe, Canada, South Africa, Middle East and China

Differential Blood Pressure Effects of Ibuprofen, Naproxen, and Celecoxib in Patients with Arthritis

The Viborg Vascular (VIVA) Randomised Screening Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content